戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 th DHT in combination with the anti-androgen cyproterone acetate.
2 orticoid spironolactone and the antiandrogen cyproterone acetate.
3  standardized GAHT, comprising estrogens and cyproterone acetate.
4                  FHT (E2 valerate 2 mg/d and cyproterone acetate 25 mg/d) was prescribed at baseline
5 er pretreatment with a sequential regimen of cyproterone acetate (50 mg/kg/day for 21 days) and testo
6                             AR activation by cyproterone acetate, a partial agonist that did not supp
7 This event was blocked by the anti-androgens cyproterone acetate and hydroxyflutamide.
8 sm and the pharmacokinetics of two ADT drugs Cyproterone acetate and Leuprolide acetate for individua
9                 Increasing concentrations of cyproterone acetate and mifepristone resulted in more co
10                         Molecular docking of cyproterone acetate and RU486 into the homology model fo
11 tar-Unilever rats by a sequential regimen of cyproterone acetate and testosterone propionate, followe
12 s seen only with R1881, dihydrotestosterone, cyproterone acetate, and hydroxyflutamide.
13 s, hydroxyflutamide, bicalutamide (casodex), cyproterone acetate, and RU58841, and other compounds su
14 ties of weak androgens and an AR antagonist (cyproterone acetate) are still dependent on the AR NH(2)
15 n and transdermal estradiol with mostly oral cyproterone acetate as antiandrogens in transgender wome
16                               The antagonist cyproterone acetate behaved as a full antagonist of D11F
17                                              Cyproterone acetate (CPA) is a steroidal antiandrogen us
18 xposure to hormonal treatments, particularly cyproterone acetate (CPA), has been posited to contribut
19 tetrachloride (CT), thioacetamide (THA), and cyproterone acetate (CPA).
20 hibited by the addition of the anti-androgen Cyproterone Acetate demonstrating that the effects of FG
21 ol and medroxyprogesterone) and antagonists (cyproterone acetate, hydroxyflutamide and bicalutamide).
22 ta-catenin to the AR DBD in vitro and to the cyproterone acetate-liganded AR in vivo.
23 ynthetic potent progestigens, norethynodrel, cyproterone acetate, norethindrone, and megestrol acetat
24  cells, RU486 revealed a higher potency than cyproterone acetate to prevent responses to dexamethason
25     The agonist activity of the antiandrogen cyproterone acetate was abolished in ebp1 transfectants.
26                         The steroid compound cyproterone acetate was identified in a high-throughput